| abstract |
Novel 3,3-Diphenylpropylamines of Formula I are provided herein. In such Formula, R1, R2, R3 and R4 signify specifically-recited groups, and X represents a specifically-recited tertiary amino group. Salts with physiologically-acceptable acids, and when the compounds can be in the form of optical isomers, the racemic mixture and the individual enantiomers, are also provided. Processes for preparing such 3,3-diphenylpropylamines are also provided. These compounds have been found to be useful in treating cholinergic disorders, and novel pharmaceutical compositions containing such 3,3-diphenylpropylamines are also provided. |